How Many Radiology AI Vendors Does a Practice Actually Need?

The short answer: most practices need far fewer than the market implies. Start from your bottleneck, not the catalog. If reports are slow and the routine worklist is backing up, one assistant that carries the whole read beats another detector. If one specific pathology is being missed or delayed, a single point solution aimed at it will outperform a broad platform. The reason to keep the number low is not license cost. It is that every additional vendor brings its own contract, security review, integration and, since May 2026, its own governance and monitoring obligation under the ACR practice parameter. Two or three well-chosen tools is a normal, defensible stack. Eight is a staffing problem.

Updated August 2026. Device counts below come from the FDA AI-enabled device list; clearance totals move every quarter, so check the current figure before quoting it.

How many radiology AI vendors does a practice need?

The honest answer is that there is no benchmark number, and anyone who gives you one is selling something. What there is, is a cost curve. The first AI tool a department buys is mostly a clinical decision. The fourth is mostly an operational one, because by then the marginal work of adding a vendor has overtaken the marginal clinical benefit.

Scale explains why. By the end of December 2025 the FDA had authorized 1,451 AI-enabled medical devices in total, and 1,104 of those were radiology devices, about 76% of every AI-enabled device it has ever cleared. Radiology Business reported that the agency's June 16, 2026 update added another 68 radiology algorithms cleared in just the first three months of 2026. Concentration is high at the top: GE HealthCare holds 120 radiology AI authorizations, Siemens Healthineers 89 and Philips 50. No department is going to evaluate that list one product at a time, and no department should try.

So the useful question is not how many tools exist. It is how many relationships your practice can carry properly, where carrying one properly means someone can answer what version is running, who validated it locally, and what its real-world performance looked like last quarter.

What is the difference between a point solution and a radiology AI platform?

A point solution detects one thing and hands you a flag. It is built around a specific indication, usually on one or two modalities, and it is often very good at exactly that. A platform delivers more than one capability through a single integration, contract and governance process.

The word platform hides an important split, though, and it is worth forcing vendors to be precise about which one they are. A marketplace platform distributes other companies' algorithms through one pipe: you get breadth and a single integration, but each algorithm underneath is still a distinct product with its own regulatory status and its own performance profile. A reporting-integrated assistant unifies the working read instead, flagging suspected findings, ordering the worklist and drafting the report in the place the radiologist already works. Those are different purchases that happen to share a noun.

Compiled August 2026. Application counts are each vendor's own published figure. We compare named products directly on the radiology AI alternatives hub, and the category page for the consolidated model is radiology AI platform.

Why does adding a vendor cost more than the license fee?

Because the license is the smallest line. Each new vendor typically means a separate security and privacy review, a separate BAA, a separate integration into PACS and the reporting workflow, a separate place for an alert to appear, a separate renewal date to track, and a separate person on your side who has to understand it well enough to answer questions when it misfires.

That last one is the item that gets underestimated. The technical integration is a project with an end date. The ownership is permanent. When a flag looks wrong at 2am, someone has to know whether that tool is behaving normally, and the honest state of many departments is that nobody owns tools three through six.

The financial version of the same problem is that per-seat and per-study pricing across several vendors is genuinely hard to forecast, which is why finance teams that track what the whole software stack actually costs each month tend to catch the sprawl a year before the clinical side does. If you are budgeting a stack rather than a product, our breakdown of what radiology AI costs covers what to ask for in writing, and AI CPT codes and reimbursement explains why almost none of it comes back as revenue.

What does the ACR practice parameter require?

On May 5, 2026, at the ACR annual meeting in Washington, DC, the American College of Radiology and the Society for Imaging Informatics in Medicine approved the first practice parameter for imaging AI. It is the clearest statement yet of what running AI responsibly looks like, and it is the reason vendor count is now an operational question rather than a preference.

It asks facilities to do five things: stand up an AI governance structure with clinical, technical and compliance leadership; keep a catalog of every AI tool in use, including versions and intended purposes; run local acceptance testing before any tool goes live; track real-world performance continuously to catch degradation, with predetermined stopping criteria; and meet HIPAA obligations with strong access controls and logging.

Read that list again with a six-vendor stack in mind. Four of the five items are per tool. A practice parameter is guidance rather than law, but it is the standard your peers are being measured against, and it converts every extra algorithm into recurring work rather than a one-time install.

The ACR Data Science Institute also runs Assess-AI, which it describes as the world's first AI quality registry and data service, letting a site benchmark its own algorithms against national performance data across applications including intracranial hemorrhage, pulmonary embolism and pneumothorax detection. If you are running acute detectors, that registry is the cheapest monitoring infrastructure available to you.

Are radiology AI marketplaces a shortcut?

Partly, and it is worth understanding exactly which part. A marketplace genuinely solves the integration problem: one pipe, one technical relationship, and the ability to switch an algorithm on without another six-month IT project. For a health system that wants to evaluate several vendors in the same pathway, that is a real saving.

What a marketplace does not solve is the governance problem. Every algorithm you enable still goes in the catalog, still needs local acceptance testing, and still needs someone watching its live performance. The friction that used to stop departments from over-buying was integration effort, and marketplaces remove exactly that friction. That is useful when you are deliberately trialing, and a quiet risk when nobody is counting.

How do you decide from your bottleneck instead of the catalog?

Write down where studies actually lose time in your department before you look at a single product page. The answer usually falls into one of three patterns, and each points at a different purchase.

If urgent cases are found late because they sit behind routine follow-ups, the problem is queue order, and worklist prioritization or a dedicated AI triage tool is the fix. If urgent cases are found on time but treatment starts late, the problem is coordination, and the acute triage vendors compared in Aidoc vs Viz.ai vs RapidAI are built for exactly that. If nothing is dramatically wrong but the reports simply take too long and the backlog grows every week, the problem is throughput on ordinary studies, and no detector will touch it. That is a structured reporting and drafting problem.

Most departments discover the third pattern once they look, which is inconvenient because the third pattern is the one the AI market talks about least.

What should you ask before adding another vendor?

Four questions, in this order. Which measured bottleneck does this close, and how will we know in ninety days whether it did? Who on our staff owns this tool, by name, after go-live? What does local acceptance testing look like for it, and will the vendor support that? And what does year three cost, fully loaded, including integration and renewal rather than just the license?

A vendor that answers all four cleanly is usually worth adding. A vendor that cannot name the bottleneck it closes is a product looking for a problem, and the department pays for that mismatch every month afterwards. Our longer list of radiology AI vendor evaluation questions is designed to be sent to every name on a shortlist in the same email, so the answers arrive in a comparable form.

Where Radiological.ai fits

Radiological.ai is built for the third pattern: the routine worklist rather than one indication. It flags suspected findings for a second look, prioritizes studies so time-critical cases surface first, and drafts the structured report into your template across X-ray, CT and MRI, so one tool covers work that would otherwise mean several. It is decision support. Every flag is a prompt for review and every report is a draft, and the responsible radiologist reviews, edits and signs each study.

If you want the category view first, the radiology AI platform page compares the three buying models side by side, and the AI radiology software roundup lists the named vendors worth knowing in each one.